Dynatrace shares advanced 2.7% in pre-market trading on Tuesday, lifting the stock toward $50.35 and nearing its 52-week high of $53.28. The gains followed a series of analyst upgrades and price target increases.
Morgan Stanley upgraded Dynatrace from Equalweight to Overweight and raised its price target to $65 from $58, citing expectations that the company’s constant-currency net-new annual recurring revenue (ARR) growth will recover to above 20% by fiscal 2027 and remain elevated through fiscal 2029. Baird also raised its target to $62 from $45 while maintaining an Outperform rating. Goldman Sachs lifted its price target to $57 from $50 with a Buy rating, and UBS reiterated its Buy rating with a $65 target.
UBS highlighted a 41% year-over-year increase in Dynatrace’s first-quarter organic net-new ARR, while Morgan Stanley pointed to a structural tailwind: a renewal cohort of Dynatrace Platform Subscription customers expected to be roughly 50% larger than prior cohorts.
The stock’s momentum comes ahead of Dynatrace’s pending acquisition of AI observability firm Arize for approximately $915 million in a cash-and-stock deal. The transaction is positioned as a strategic move to bolster the company’s AI capabilities.
Broader equity markets showed modest gains in pre-market trading, with the S&P 500 up 0.5% and the Nasdaq gaining 0.9%.
